z-logo
open-access-imgOpen Access
Association of Direct-Acting Antiviral Therapy for Hepatitis C With After-Treatment Costs Among Medicare Beneficiaries
Author(s) -
Jeah Jung,
Roger Feldman,
Yamini Kalidindi,
Thomas Riley
Publication year - 2020
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2020.8081
Subject(s) - antiviral therapy , medicine , hepatitis c , association (psychology) , chronic hepatitis , virology , psychology , psychotherapist , virus
This cohort study analyzes the cost implications for Medicare of direct-acting antiviral medications used by beneficiaries with or without hepatitis C–related liver disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom